Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction

SM16, an Orally Active TGF-β Type I Receptor Inhibitor Prevents Myofibroblast Induction and Vascular Fibrosis in the Rat Carotid Injury Model

(2008) Kai Fu et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Transforming growth factor beta inhibition increases mortality and left ventricular dilatation after myocardial infarction

(2008) Stefan Frantz et al.   BASIC RESEARCH IN CARDIOLOGY

Heart Disease and Stroke Statistics—2009 Update

(2008) et al.   CIRCULATION

Transforming Growth Factor-β Blockade Down-Regulates the Renin-Angiotensin System and Modifies Cardiac Remodeling after Myocardial Infarction

(2008) Leigh J. Ellmers et al.   ENDOCRINOLOGY

Macrophage roles following myocardial infarction

(2008) Jessica M. Lambert et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis

(2007) M. Petersen et al.   KIDNEY INTERNATIONAL